Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Rifapentine

U.S. FDA Requirements: Rifapentine

Pharmaceutical / Drug Definition : Inhibits RNA synthesis by blocking RNA transcription in susceptible organisms (mycobacteria and some gram-positive and gram-negative bacteria

Registrar Corp assists Rifapentine companies with:

  • FDA Registration Rifapentine
  • FDA Listing Rifapentine
  • FDA Label Requirements and Exceptions Rifapentine
  • FDA Import Information Rifapentine
  • FDA Detentions Rifapentine (Rifapentine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Rifapentine (Rifapentine Suppliers)
       - Processors Rifapentine
       - Repackers Rifapentine
       - Relabelers Rifapentine
       - Exporters Rifapentine
       - Importers Rifapentine
For more information about Rifapentine, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco